Are placebo run ins justified?

BMJ

Volumn 314, Issue 7088, 1997, Pages 1191-

  Senn, Stephen ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUBJECT;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

DISCLOSURE; ETHICS, MEDICAL; HUMANS; INFORMED CONSENT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RESEARCH SUBJECTS; TRUTH DISCLOSURE;

EID: 0031578091     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.314.7088.1191     Document Type: Article

References (18)

1. Aspinall RL, Goodman NW. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondanestron for postoperative nausea and vomiting: a review of published trials. BMJ 1995; 311: 844–6.
2. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994; 331: 394–8.
3. Senn SJ. A personal view of some controversies in allocating treatment to patients in clinical trials. Stat Med 1995; 14: 2661–74.
4. Senn SJ. Fisher's game with the devil. Stat Med 1994; 13: 217–30
5. Fisher RA. The design of experiments. Reprinted in: Bennett JH, ed. Statistical methods, experimental design and scientific inference. Oxford: Oxford University Press, 1990.
6. Freedman B. Placebo-controlled trials and the logic of clinical purpose. IRB: A Review of Human Subjects Research 1990; 12: 1–6.
7. Hulley SB, Cummings SR. Designing clinical research: an epidemiologic approach. Baltimore: William and Wilkins, 1988.
8. Spilker B. Guide to clinical trials. New York: Raven, 1991.
9. Pocock SJ. Clinical trials. Chichester: Wiley, 1983.
10. Steering Committee of the Physicians' Health Study Research Group. Preliminary report: findings from the aspirin component of the ongoing physicians' health study. N Engl J Med 1988; 318: 262–4.
11. Lang JM. The use of a run-in to enhance compliance. Stat Med 1990; 9: 87–95.
12. Lang JM, Buring JE, Rosner B, Cook N, Hennekens CH. Estimating the effect of the run-in on the power of the physician's health study. Stat Med 1991; 10: 1585–93.
13. Buring JE, Hennekens CH. Cost and efficiency in clinical trials: the US physicians' health study. Stat Med 1990; 9: 29–33.
14. Brittain J, Wittes J. The run-in period in clinical trials: the effect of misclassification on efficiency. Con Clin Trials 1990; 11: 327–38.
15. Schechtman KB, Gordon ME. A comprehensive algorithm for determining whether a run-in strategy will be a cost-effective design modification in a randomised clinical trial. Stat Med 1993; 12: 111–28.
16. Temple R. Government viewpoint of clinical trials. Drug Inf J 1982; 16: 10–7.
17. Senn SJ. Falsificationism and clinical trials. Stat Med 1991; 10: 1361–74.
18. Mitchell J. A fundamental problem of consent. BMJ 1995; 310: 43–6.